Maxime Dely: Trends in Red Blood Cell Consumption in France
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Trends in Red Blood Cell (RBC) consumption in France
- A steady decline over the past decade
Over the last ten years, a clear trend has emerged: overall RBC consumption in France has been steadily decreasing.
This evolution is largely driven by major advances in medical and surgical practices. Procedures are now more targeted and minimally invasive, with better anticipation of bleeding risks.
At the same time, transfusion best practices have evolved significantly: the goal is no longer to transfuse more, but to transfuse appropriately, avoiding unnecessary over-transfusion.
- Fewer standard RBC units, but more relevant transfusion strategies.
- A significant shift in the nature of transfusion needs
This overall decline does not mean that transfusion challenges are disappearing. On the contrary, the profile of needs is changing.
In France, a genetic disease remains highly prevalent: sickle cell disease.
These patients often require regular red blood cell exchange transfusions, frequently performed through erythrocytapheresis, and depend on RBC units with rare blood group phenotypes.
- A dual dynamic to consider
We are now facing a clear correlation: a decrease in standard RBC consumption, alongside an increase in demand for highly specific and rare RBC units.
- A direct impact on donor recruitment strategies
This shift is profoundly reshaping donor recruitment and communication strategies.
Where “standard” donor profiles were largely sufficient 10–15 years ago, there is now a growing need for targeted outreach, focused on donors with rare blood groups.
- Transfusion medicine is evolving.
- Blood donor recruitment must evolve with it.”
Find more posts featuring Maxime Dely on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda